Vcare Pharmatech Overview
- Year Founded
-
2010
- Status
-
Private
- Employees
-
900
- Latest Deal Type
-
2ndary - Private
- Investors
-
19
Vcare Pharmatech General Information
Description
Developer of innovative drugs designed to treat cardiovascular and cerebrovascular diseases, tumors, endocrine diseases, and other areas of chronic disease. The company's drugs focus on chemical molecular structure optimization and differentiated solutions to clinical needs in the form of generic and innovative drugs and featured pharmaceutical intermediates, providing research and development services for the whole industry chain of chemical drugs.
Contact Information
Website
www.vcarepharmatech.comCorporate Office
- Number 136 Huakang Road, Jiangbei New District
- Nanjing, Jiangsu 210000
- China
Corporate Office
- Number 136 Huakang Road, Jiangbei New District
- Nanjing, Jiangsu 210000
- China
Vcare Pharmatech Timeline
Vcare Pharmatech Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Secondary Transaction - Private | 05-Nov-2026 | Completed | Clinical Trials - General | |||
| 9. Later Stage VC (Series C3) | 02-Jun-2026 | Completed | Clinical Trials - General | |||
| 8. Later Stage VC (Series C1) | 01-Dec-2024 | Completed | Clinical Trials - General | |||
| 7. Later Stage VC (Series C) | 29-Dec-2023 | Completed | Clinical Trials - General | |||
| 6. Later Stage VC (Series B) | 23-Dec-2022 | Completed | Clinical Trials - General | |||
| 5. Later Stage VC (Series A2) | 12-Apr-2022 | Completed | Clinical Trials - General | |||
| 4. Later Stage VC (Series A1) | 30-Jul-2021 | Completed | Clinical Trials - General | |||
| 3. Later Stage VC (Series A) | 25-Feb-2021 | Completed | Clinical Trials - General | |||
| 2. Secondary Transaction - Private | 29-Dec-2020 | $16.9M | Completed | Clinical Trials - General | ||
| 1. Merger/Acquisition | 01-Mar-2015 | $24M | Completed | Clinical Trials - General |
Vcare Pharmatech Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Vcare Pharmatech Patents
Vcare Pharmatech Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026214762-A1 | Btk degrader and use thereof | Pending | 11-Apr-2025 | ||
| WO-2026200984-A1 | Er-protac compound for targeted degradation of estrogen receptor and use thereof | Pending | 25-Mar-2025 | ||
| WO-2026067743-A1 | Small molecule compound as il-17 modifier | Pending | 29-Sep-2024 | ||
| WO-2025152991-A1 | Mat2a inhibitor and use thereof | Pending | 15-Jan-2024 | ||
| EP-4821926-A1 | Estrogen receptor modulator and use thereof | Pending | 08-Dec-2023 | C07D401/04 |
Vcare Pharmatech Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Vcare Pharmatech Investors (19)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Chengdu Dianke Venture Capital | Growth/Expansion | Minority | ||
| Jinlong Group | Asset Manager | Minority | ||
| Shandong Xinghe Venture Capital Management | Growth/Expansion | Minority | ||
| State Development and Investment Group | Government | Minority | ||
| China Life Private Equity | PE/Buyout | Minority |
Vcare Pharmatech FAQs
-
When was Vcare Pharmatech founded?
Vcare Pharmatech was founded in 2010.
-
Where is Vcare Pharmatech headquartered?
Vcare Pharmatech is headquartered in Nanjing, China.
-
What is the size of Vcare Pharmatech?
Vcare Pharmatech has 900 total employees.
-
What industry is Vcare Pharmatech in?
Vcare Pharmatech’s primary industry is Drug Discovery.
-
Is Vcare Pharmatech a private or public company?
Vcare Pharmatech is a Private company.
-
What is Vcare Pharmatech’s current revenue?
The current revenue for Vcare Pharmatech is .
-
How much funding has Vcare Pharmatech raised over time?
Vcare Pharmatech has raised $255M.
-
Who are Vcare Pharmatech’s investors?
Chengdu Dianke Venture Capital, Jinlong Group, Shandong Xinghe Venture Capital Management, State Development and Investment Group, and China Life Private Equity are 5 of 19 investors who have invested in Vcare Pharmatech.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
